Cascade Financial Partners »

AstraZeneca shares owned by Cascade Financial Partners

Quarter-by-quarter ownership of AstraZeneca shares owned by Cascade Financial Partners from 13F filings

Historical chart of Cascade Financial Partners investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Cascade Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Cascade Financial Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $202k 2.2k 91.92

More positions owned by Cascade Financial Partners

Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Pepsi (PEP)
NVIDIA Corporation (NVDA)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Wisdomtree Tr True Developed I (DOL)
PerkinElmer (RVTY)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust State Street Spd (SPMD)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)

View all positions for Cascade Financial Partners

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Ameriprise Financial
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca